Publication Cover
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 40, 2018 - Issue 11
388
Views
46
CrossRef citations to date
0
Altmetric
Original Research Paper

Preoperative neutrophil–lymphocyte ratio correlated with glioma grading and glioblastoma survival

, , , &
Pages 917-922 | Received 18 Apr 2018, Accepted 01 Jul 2018, Published online: 03 Aug 2018

References

  • Han S, Liu Y, Li Q, et al. Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma. BMC Cancer. 2015 Sep;04(15):617.
  • Malietzis G, Giacometti M, Kennedy RH, et al. The emerging role of neutrophil to lymphocyte ratio in determining colorectal cancer treatment outcomes: a systematic review and meta-analysis. Ann Surg Oncol. 2014 Nov;21(12):3938–3946.
  • Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005 Sep 01;91(3):181–184.
  • Boegemann M, Schlack K, Thomes S, et al. The role of the neutrophil to lymphocyte ratio for survival outcomes in patients with metastatic castration-resistant prostate cancer treated with abiraterone. Int J Mol Sci. 2017 11;18(2):Feb.
  • Gondo T, Nakashima J, Ohno Y, et al. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy. Urology. 2012 May;79(5):1085–1091.
  • Tang X, Wang S, An C, et al. Preoperative high neutrophil-to-lymphocyte ratio is associated with high-grade bladder cancer. Anticancer Res. 2017 Aug;37(8):4659–4663.
  • Macfarlane MJ, Macfarlane LL, Scase T, et al. Use of neutrophil to lymphocyte ratio for predicting histopathological grade of canine mast cell tumours. Vet Rec. 2016 Nov 12;179(19):491.
  • Yuan D, Zhu K, Li K, et al. The preoperative neutrophil-lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction. J Surg Oncol. 2014 Sep;110(3):333–340.
  • Zadora P, Dabrowski W, Czarko K, et al. Preoperative neutrophil-lymphocyte count ratio helps predict the grade of glial tumor - a pilot study. Neurol Neurochir Pol. 2015;49(1):41–44.
  • Muller C, Holtschmidt J, Auer M, et al. Hematogenous dissemination of glioblastoma multiforme. Sci Transl Med. 2014 Jul 30;6(247):247ra101.
  • Karnofsky DA, Patterson PA, Ridgway LP. Effect of folic acid, 4-amino folic acids and related substances on growth of chick embryo. Proc Soc Exp Biol Medicine. Soc Exp Biol Med. 1949 Jul;71(3):447–452.
  • Stupp R, Mason WP, Van Den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005 Mar 10;352(10):987–996.
  • Wang PF, Liu N, Song HW, et al. IDH-1R132H mutation status in diffuse glioma patients: implications for classification. Oncotarget. 2016 May 24;7(21):31393–31400.
  • Bambury RM, Teo MY, Power DG, et al. The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme. J Neurooncol. 2013 Aug;114(1):149–154.
  • McNamara MG, Lwin Z, Jiang H, et al. Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression. J Neurooncol. 2014 Mar;117(1):147–152.
  • Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010 Mar 19;140(6):883–899.
  • Gregory AD, Houghton AM. Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res. 2011 Apr 01;71(7):2411–2416.
  • Del Prete A, Allavena P, Santoro G, et al. Molecular pathways in cancer-related inflammation. Biochemia Medica. 2011;21(3):264–275.
  • Mitsuya K, Nakasu Y, Kurakane T, et al. Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of worse survival after resection in patients with brain metastasis. J Neurosurg. 2017 Aug;127(2):433–437.
  • Fossati G, Ricevuti G, Edwards SW, et al. Neutrophil infiltration into human gliomas. Acta Neuropathol. 1999 Oct;98(4):349–354.
  • Samaras V, Piperi C, Levidou G, et al. Analysis of interleukin (IL)-8 expression in human astrocytomas: associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry. Hum Immunol. 2009 Jun;70(6):391–397.
  • Wang PF, Song HW, Cai HQ, et al. Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival. Oncotarget. 2017 Jul 25;8(30):50117–50123.
  • Wainwright DA, Sengupta S, Han Y, et al. Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors. Neuro Oncol. 2011 Dec;13(12):1308–1323.
  • Guthrie GJ, Charles KA, Roxburgh CS, et al. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013 Oct;88(1):218–230.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.